Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Emily C. Liang(Fred Hutch Cancer Center), Jordan Gauthier(Seattle Cancer Care Alliance), David G. Maloney(Fred Hutch Cancer Center), Andrew J. Portuguese(University of Washington), Aude G. Chapuis(University of Washington), Brian G. Till(University of Washington), Alexandre V. Hirayama(University of Washington), Mazyar Shadman(University of Washington), Filippo Milano(Fred Hutch Cancer Center), Hans‐Peter Kiem(Fred Hutch Cancer Center), Aya Albittar(University of Washington), Ryan D. Cassaday(University of Washington), Stanley R. Riddell(Fred Hutch Cancer Center), Cameron J. Turtle(The University of Sydney), Jennifer J. Huang(Stanford Medicine), Erik L. Kimble(University of Washington)
Cited by 34
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k